Clark Estates Inc’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.51M Hold
44,868
0.81% 21
2026
Q1
$2.9M Hold
44,868
0.7% 20
2025
Q4
$3.02M Hold
44,868
0.73% 19
2025
Q3
$3.29M Hold
44,868
0.75% 23
2025
Q2
$2.33M Hold
44,868
0.52% 27
2025
Q1
$2.86M Sell
44,868
-17,132
-28% -$995K 0.61% 23
2024
Q4
$2.96M Buy
+62,000
New +$3.18M 0.57% 41

Other funds holding HALO

Clark Estates Inc's HALO Position: Q2 2026 in Review

Clark Estates Inc held its Halozyme (HALO) position steady in Q2 2026 at 44,868 shares worth $3.51M. The position accounts for 0.81% of the portfolio, ranked #21.

Clark Estates Inc first reported a position in HALO in Q4 2024 and has held it in 7 quarters since. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Clark Estates Inc held 44,868 shares of Halozyme worth $3.51M as of Q2 2026.
  • Clark Estates Inc left its Halozyme share count unchanged in Q2 2026.
  • Halozyme made up 0.81% of Clark Estates Inc's portfolio in Q2 2026, its #21 holding.
  • Clark Estates Inc first reported a position in Halozyme in Q4 2024 and has held it in 7 quarters since.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Clark Estates Inc's 13F filing for Q2 2026, filed 5 Aug 2026.